What are the clinical limitations of the Glasgow Coma Scale in assessing concussion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Limitations of the Glasgow Coma Scale for Concussion

The GCS was never designed to assess concussion or mild traumatic brain injury—it was specifically created for comatose patients with severe head injuries requiring at least 6 hours of coma, making a single GCS score of limited prognostic value and insufficient to determine the degree of brain injury in concussion patients. 1

Historical Context and Design Limitations

The GCS was developed in 1974 by Teasdale and Jennett as a standardized tool for serial neurologic assessments of comatose patients in the pre-CT era. The scale was designed to:

  • Facilitate communication between rotating care providers
  • Enable relatively inexperienced providers to perform serial evaluations
  • Not diagnose mild or moderate TBI
  • Not replace a comprehensive neurologic examination 1

Critical Limitations in Concussion Assessment

1. Poor Sensitivity for Detecting Significant Injury

  • Approximately 13% of patients who became comatose had an initial GCS of 15 1
  • Up to 15% of patients with GCS 15 will have acute lesions on CT imaging 1
  • Patients with GCS 13-15 and intraparenchymal lesions perform on neuropsychological testing similar to those with moderate TBI (GCS 9-12), despite having "mild" GCS scores 1

2. Single Score Provides Inadequate Information

A single GCS determination cannot be used solely in diagnosing mild TBI. 1 The value lies in serial determinations:

  • A high GCS that decreases predicts poorer outcomes
  • A low GCS that improves predicts better outcomes
  • Static scores miss evolving pathology 1

3. Ceiling Effect at High Scores

The GCS performs poorly at distinguishing between patients with GCS 14-15, where most concussion patients fall. At these ceiling scores, the scale cannot capture:

  • Loss of consciousness duration
  • Post-traumatic amnesia
  • Confusion or disorientation
  • Subtle cognitive deficits
  • Memory dysfunction 1

4. Misses Key Concussion Features

The GCS does not assess critical concussion symptoms:

  • Post-traumatic amnesia (a key diagnostic criterion)
  • Retrograde amnesia
  • Confusion without altered consciousness
  • Vestibulo-oculomotor dysfunction
  • Cognitive impairment at normal consciousness levels 1

5. Cannot Predict Post-Concussive Syndrome

The GCS provides no information about risk for:

  • Prolonged post-concussive symptoms
  • Neurocognitive sequelae lasting days to months
  • Functional disability at 1 year (affects 5-15% of mild TBI patients) 1

Practical Clinical Pitfalls

Confounding Factors

Multiple factors affect GCS accuracy that are common in concussion settings:

  • Intoxication (alcohol, drugs)
  • Sedation or pain medications
  • Language barriers
  • Hearing impairment
  • Intubation (verbal component cannot be assessed)
  • Facial trauma preventing eye opening
  • Spinal cord injury affecting motor response 2, 3

User Error

Studies demonstrate significant inaccuracy when assessed by inexperienced providers:

  • Average 26% failure rate in providing correct GCS profiles
  • Primary errors in assessing "confused conversation" (V4) and "withdrawal motor response" (M4)
  • Inconsistent timing of assessments
  • Poor inter-rater reliability 4, 3

What Should Be Used Instead

For proper concussion assessment, document:

Essential Components:

  • Detailed GCS with all three components (eye, verbal, motor) separately recorded
  • Confounding factors clearly documented
  • Loss of consciousness: presence and duration (<30 minutes for mild TBI)
  • Post-traumatic amnesia: presence and duration (<24 hours for mild TBI) using validated tools
  • Acute symptoms: confusion, disorientation, feeling "dazed"
  • Pupillary reactivity (documented separately, not as GCS-P)
  • Serial assessments over time, not single measurements 1, 5

Additional Critical Variables:

  • Mechanism of injury
  • Neurological deficits
  • Vital signs (can reveal more about neurological status than GCS alone) 6
  • CT findings when indicated
  • Extracranial injuries 5

Bottom Line for Clinical Practice

Do not rely on a single GCS score to rule out significant brain injury or predict outcomes in concussion patients. The GCS 15 patient who appears "neurologically intact" may harbor life-threatening intracranial injury or develop significant post-concussive disability. Serial GCS measurements combined with detailed assessment of loss of consciousness, amnesia, and acute symptoms provide far superior clinical information. When head CT is unavailable, serial GCS scores remain the best method for detecting patients requiring neurosurgical intervention, but the emphasis must be on serial rather than single determinations. 1

The 2023 ACEP guidelines now recommend that GCS 13 should not be considered mild TBI due to higher rates of surgical intervention and worse outcomes in this group, further highlighting the scale's limitations in the mild injury spectrum. 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.